gliclazide has been researched along with Urinary Bladder Neoplasms in 1 studies
Gliclazide: An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion.
Urinary Bladder Neoplasms: Tumors or cancer of the URINARY BLADDER.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Gliclazide is a widely used sulfonylurea hypoglycemic drug, but its cancer risk remains controversial." | 5.51 | Mutations in gliclazide-associated genes may predict poor bladder cancer prognosis. ( Chen, H; Gong, J; Sun, J; Wang, M; Wen, W; Wu, P; Zhao, M, 2019) |
| "Gliclazide is a widely used sulfonylurea hypoglycemic drug, but its cancer risk remains controversial." | 1.51 | Mutations in gliclazide-associated genes may predict poor bladder cancer prognosis. ( Chen, H; Gong, J; Sun, J; Wang, M; Wen, W; Wu, P; Zhao, M, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wen, W | 1 |
| Gong, J | 1 |
| Wu, P | 1 |
| Zhao, M | 1 |
| Wang, M | 1 |
| Chen, H | 1 |
| Sun, J | 1 |
1 other study available for gliclazide and Urinary Bladder Neoplasms
| Article | Year |
|---|---|
Mutations in gliclazide-associated genes may predict poor bladder cancer prognosis.
Topics: Antineoplastic Agents; Diabetes Mellitus; Gliclazide; Humans; Hypoglycemic Agents; Mutation; Phospha | 2019 |